Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs

J. A. Roth, D. L. Morton, E. C. Holmes

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Dinitrophenylation of tumor cells was investigated as a method for augmenting tumor cell antigenicity in the DNCB-sensitized host. Strain-2 guinea pigs were hyper-immunized to DNCB by intradermal injection. A syngeneic methylcholanthrene-induced sarcoma (MCA-25), was conjugated to DNCB without significant loss of viability. DNCB-Sensitized animals and unsensitized animals were injected intradermally on opposite flanks with conjugated and unconjugated tumor cells. DNCB-Conjugated tumor cells produced significantly fewer tumors in DNCB-sensitized animals (8/21) when compared to unsensitized animals (17/22). The growth of unconjugated tumor cells was significantly inhibited by the simultaneous injection of conjugated tumor cells in DNCB-sensitized animals. DNCB sensitization did not affect tumor growth in a control group receiving unconjugated tumor cells. DNCB sensitization, therefore, will induce immunity to the hapten-tumor cell conjugate.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalJournal of Surgical Research
Volume25
Issue number1
DOIs
StatePublished - Jul 1978

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs'. Together they form a unique fingerprint.

Cite this